Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Coron Artery Dis ; 24(3): 196-200, 2013 May.
Article in English | MEDLINE | ID: mdl-23283030

ABSTRACT

BACKGROUND: We aimed to examine the association between plasminogen activator inhibitor-1 (PAI-1) genetic polymorphism and early spontaneous recanalization in patients presenting with acute ST-elevation myocardial infarction. METHODS: Patients admitted to our emergency department with ST-elevation myocardial infarction in the first 6 h of symptom onset were included. An immediate primary percutaneous coronary intervention was performed. Patients were grouped according to the initial patency of the infarct-related artery (IRA) as follows: total occlusion (TO) group [Thrombolysis in Myocardial Infarction (TIMI) 0-1 flow in the IRA], partial recanalization group (TIMI 2 flow in the IRA), and complete recanalization (CR) group (TIMI 3 flow in the IRA). PAI-1 4G/5G polymorphism was detected using the real-time PCR method. RESULTS: There were 107 patients in the TO group, 30 patients in the partial recanalization group, and 45 patients in the CR group. When we evaluated degrees of patency according to the PAI-1 genotype, TO of the IRA was the highest in patients with the PAI 4G/4G genotype (PAI-1 4G/4G: 66.7%, PAI-1 4G/5G: 65.9%, PAI-1 5G/5G: 40.4%) and CR of the IRA was the highest in patients with the PAI 5G/5G genotype (PAI-1 5G/5G: 38.5%, PAI-1 4G/5G: 19.8%, PAI-1 4G/4G: 17.9%). The distribution of genotypes in different degrees of patency of IRA was statistically significant (P=0.029). In logistic regression analysis, the PAI-1 5G/5G genotype was associated independently with the spontaneous CR of the IRA (odds ratio: 2.875, 95% confidence interval [1.059-7.086], P=0.038). CONCLUSION: Patients with the PAI-1 5G/5G genotype seem to be luckier than others in terms of early spontaneous recanalization of the IRA. Further prospective studies with large patient populations are required for more precise results.


Subject(s)
Coronary Occlusion/genetics , Coronary Vessels/physiopathology , Myocardial Infarction/genetics , Plasminogen Activator Inhibitor 1/genetics , Polymorphism, Genetic , Vascular Patency/genetics , Adult , Aged , Chi-Square Distribution , Coronary Angiography , Coronary Occlusion/complications , Coronary Occlusion/diagnostic imaging , Coronary Occlusion/physiopathology , Coronary Occlusion/therapy , Coronary Vessels/diagnostic imaging , Electrocardiography , Female , Gene Frequency , Genetic Predisposition to Disease , Humans , Logistic Models , Male , Middle Aged , Myocardial Infarction/diagnostic imaging , Myocardial Infarction/physiopathology , Myocardial Infarction/therapy , Odds Ratio , Percutaneous Coronary Intervention , Phenotype , Prognosis , Real-Time Polymerase Chain Reaction , Risk Factors , Severity of Illness Index
2.
Horm Res Paediatr ; 73(3): 166-74, 2010.
Article in English | MEDLINE | ID: mdl-20197668

ABSTRACT

Cardiovascular risk starts early in life; therefore, it is of interest to clarify the relation between puberty, sex hormones, insulin resistance and lipid levels in children. This is a cross sectional study of 365 school students (8-18 years of age). We analyzed the associations of sex hormones (testosterone, free androgen index, estradiol, free estradiol index) and sex hormone-binding globulin (SHBG) with insulin resistance and lipid levels. Analyses were performed in prepubertal versus adolescent girls and boys. Among prepubertal boys, estradiol was significantly associated with increased log homeostasis model assessment-estimated insulin resistance (HOMA-IR; B = 0.9, model R(2) = 0.62, p < 0.001) and insulin levels (B = 0.8, model R(2) = 0.58, p < 0.001). Testosterone was associated with increased high-density lipoprotein cholesterol (HDL-C) levels among prepubertal boys (B = 10, model R(2) = 0.42, p = 0.04). Among adolescent girls, SHBG was significantly associated with decreased HOMA-IR (B = -0.8, model R(2) = 0.34, p = 0.01) and insulin levels (B = -0.7, model R(2) = 0.34, p = 0.01). SHBG was also related to increased HDL-C levels among prepubertal (B = 24, model R(2) = 0.42, p = 0.047) and adolescent girls (B = 21, model R(2) = 0.44, p = 0.002). In conclusion, sex hormone levels and SHBG have important effects on HDL-C and insulin resistance among children and adolescents.


Subject(s)
Cholesterol, HDL/blood , Gonadal Steroid Hormones/blood , Insulin Resistance , Lipids/blood , Sex Hormone-Binding Globulin/analysis , Adolescent , Child , Cross-Sectional Studies , Estradiol , Female , Heart Diseases/etiology , Humans , Male , Puberty/physiology , Risk Factors , Testosterone
3.
Acta Cardiol ; 64(6): 747-54, 2009 Dec.
Article in English | MEDLINE | ID: mdl-20128150

ABSTRACT

OBJECTIVE: Understanding intercultural, regional and interracial differences in blood pressure and anthropometric indices may help to determine the contributors of mortality from coronary artery disease in different populations. DESIGN AND SETTING: In this article we used data collected from two different countries: (a) Survey on school children from Istanbul, Turkey, (b) Cross Sectional Study of Albanian school children. RESULTS: We compared age- and gender-matched Albanian and Turkish children and adolescents (age 11-12 y and 15-17 y) living in 2 different countries with regard to blood pressure, weight, height, body mass index (BMI), waist circumference, hip circumference, waist-to-hip (WHpR) and waist-to-height (WHtR) ratio. We observed significant differences in blood pressure, BMI and other anthropometric indices among age- and gender-matched subjects from the two countries. Birthweight was lower among Turkish children and adolescents compared to Albanian subjects (3258 vs. 3510 g, P < 0.01). Turkish children had lower BMI and WHtR compared to Albanian children, while adolescents displayed similar BMI and WHtR. Paradoxically, Turkish children and adolescents displayed higher systolic blood pressures compared to Albanian children and adolescents. Significant differences were observed in the dietary intake and physical activity, which may partially explain the differences in blood pressure and anthropometric indices. CONCLUSIONS: The socio-economic, dietary and physical activity status may account for significant differences in blood pressure and anthropometric indices of children and adolescents living in two different countries. Future studies should focus on the ethnic differences in the definition and prevention of cardiovascular risks among children and adolescents.


Subject(s)
Body Weights and Measures , Adolescent , Albania/epidemiology , Birth Weight , Blood Pressure , Body Mass Index , Child , Cross-Sectional Studies , Female , Humans , Male , Overweight/epidemiology , Prevalence , Turkey/epidemiology , Waist-Hip Ratio
4.
J Thromb Thrombolysis ; 27(2): 172-4, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18183354

ABSTRACT

BACKGROUND: Gonadotropin releasing hormone (GnRH) agonists are the cornerstone of metastatic prostate cancer treatment. Cardiovascular effects of GnRH agonists are unclear. In this study, we investigated the short term effects of GnRH agonists on plasma fibrinolytic parameters in patients with metastatic prostate cancer. METHODS: Eleven patients (mean age 69.3 +/- 6.5) with metastatic prostate cancer and a clinical indication for GnRH agonist therapy were selected. Plasma plasminogen activator inhibitor (PAI-1) antigen (Ag), tissue plasminogen activator (t-PA) Ag and thrombin-activatable fibrinolysis inhibitor (TAFI) activity levels were measured at baseline and at 4 weeks after the first dose of GnRH agonist, Goserelin Acetate (Zoladex, subcutaneous administration, 10.8 mg). RESULTS: Serum prostate specific antigen (PSA) levels significantly decreased from 36.6 +/- 19.3 to 1.1 +/- 0.3 ng/ml after Goserelin acetate treatment (P = 0.005). Significant changes occurred in the fibrinolytic parameters. GnRH agonists decreased plasma t-PA Ag levels (16.3 +/- 4.9 vs. 12.2 +/- 2.8 ng/ml, P = 0.047) and increased PAI-1/t-PA molar ratio (4.8 +/- 3.6 vs. 6.6 +/- 3.4, P = 0.16), on the other hand, plasma PAI-1 Ag (59.0 +/- 48.5 vs. 56.4 +/- 30.5 ng/ml, P = 0.8), and TAFI levels (130.6 +/- 9.5 vs. 124.2 +/- 26.5% activity, P = 0.3) did not change significantly. CONCLUSION: This study provides evidence that GnRH agonists may inhibit fibrinolytic system by decreasing t-PA levels.


Subject(s)
Fibrinolysis/drug effects , Gonadotropin-Releasing Hormone/agonists , Goserelin/pharmacology , Prostatic Neoplasms/blood , Prostatic Neoplasms/drug therapy , Aged , Biomarkers/blood , Goserelin/therapeutic use , Hemostasis/drug effects , Humans , Male , Middle Aged , Prostate-Specific Antigen/blood , Tissue Plasminogen Activator/blood , Tissue Plasminogen Activator/drug effects
5.
Article in English | MEDLINE | ID: mdl-18404606

ABSTRACT

INTRODUCTION: Angiotensin-converting enzyme (ACE) inhibitors reduce cardiovascular events in patients with established vascular disease and heart failure (HF). ACE-inhibitors have important effects on fibrinolytic balance, which may be the underlying mechanism for a reduction in cardiovascular events. Although angiotensin-receptor blockers (ARBs) offer greater tolerability than ACE-inhibitors, the major ARB trials have demonstrated a lack of reduction in myocardial infarction (MI) occurrence and mortality in contrast to ACE-inhibitors. In this study, we investigated the combined effects of ARBs and ACE-inhibitors on fibrinolytic and inflammatory parameters in patients with uncontrolled hypertension. METHODS: Twenty-four patients with uncontrolled hypertension despite taking adequate doses of ACE-inhibitor therapy were selected. Patients were started on Candesartan 16 mg once a day. Plasma plasminogen activator inhibitor (PAI-1) antigen (Ag), tissue plasminogen activator (t-PA) Ag, thrombin-activatable fibrinolysis inhibitor (TAFI) % activity and high sensitivity C-reactive protein (hsCRP) levels, were measured during low salt intake at baseline and two weeks after therapy with an ARB. RESULTS: Addition of ARB to the regimen reduced systolic (155+/-17 vs. 139+/-13, p<0.001), and diastolic (91+/-9 vs. 81+/-8, p<0.001) blood pressures (BP). No significant changes were observed in PAI-1 Ag (66+/-51 vs. 68+/-52, p=0.9), t-PA Ag (12.6+/-5.3 vs. 13.3+/-4.7, p=0.3), TAFI % activity (119+/-30 vs. 118+/-32, p=0.9) and hsCRP (3.9+/-3.4 vs. 3.6+/-3.6, p=0.7) levels after adding an ARB. CONCLUSIONS: Combined ARB and ACE-inhibitor use provide better BP control without any detrimental effect in plasma inflammatory and fibrinolytic parameters.


Subject(s)
Angiotensin Receptor Antagonists , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Benzimidazoles/therapeutic use , Blood Pressure/drug effects , Carboxypeptidase B2/blood , Plasminogen Activator Inhibitor 1/immunology , Tetrazoles/therapeutic use , Tissue Plasminogen Activator/immunology , Aged , Angiotensin-Converting Enzyme Inhibitors/adverse effects , Antigens/analysis , Biphenyl Compounds , Female , Humans , Male , Middle Aged , Pilot Projects
SELECTION OF CITATIONS
SEARCH DETAIL
...